IN2013MU01985A - - Google Patents
Download PDFInfo
- Publication number
- IN2013MU01985A IN2013MU01985A IN1985MU2013A IN2013MU01985A IN 2013MU01985 A IN2013MU01985 A IN 2013MU01985A IN 1985MU2013 A IN1985MU2013 A IN 1985MU2013A IN 2013MU01985 A IN2013MU01985 A IN 2013MU01985A
- Authority
- IN
- India
- Prior art keywords
- empagliflozin
- amorphous form
- preparation
- provides
- abstarct
- Prior art date
Links
- OBWASQILIWPZMG-QZMOQZSNSA-N empagliflozin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=CC=C(Cl)C(CC=2C=CC(O[C@@H]3COCC3)=CC=2)=C1 OBWASQILIWPZMG-QZMOQZSNSA-N 0.000 abstract 3
- 229960003345 empagliflozin Drugs 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 239000003085 diluting agent Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1985MU2013 IN2013MU01985A (enrdf_load_html_response) | 2013-06-10 | 2013-06-10 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1985MU2013 IN2013MU01985A (enrdf_load_html_response) | 2013-06-10 | 2013-06-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013MU01985A true IN2013MU01985A (enrdf_load_html_response) | 2015-05-29 |
Family
ID=54396291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1985MU2013 IN2013MU01985A (enrdf_load_html_response) | 2013-06-10 | 2013-06-10 |
Country Status (1)
| Country | Link |
|---|---|
| IN (1) | IN2013MU01985A (enrdf_load_html_response) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016169534A1 (en) * | 2015-04-24 | 2016-10-27 | Zentiva, K. S. | Solid forms of amorphous empagliflozin |
| CN106317035A (zh) * | 2015-06-23 | 2017-01-11 | 中美华世通生物医药科技（武汉）有限公司 | 恩格列净单晶及其制备方法和用途 |
| WO2017203457A1 (en) * | 2016-05-26 | 2017-11-30 | Dr. Reddy's Laboratories Limited | Solid state forms of empagliflozin |
| US9902751B2 (en) | 2013-12-30 | 2018-02-27 | Mylan Laboratories Limited | Process for the preparation of empagliflozin |
| US10428053B2 (en) | 2015-09-15 | 2019-10-01 | Laurus Labs Limited | Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof |
| WO2021123165A1 (en) | 2019-12-19 | 2021-06-24 | Krka, D.D., Novo Mesto | Dosage form comprising amorphous solid solution of empagliflozin with polymer |
-
2013
- 2013-06-10 IN IN1985MU2013 patent/IN2013MU01985A/en unknown
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9902751B2 (en) | 2013-12-30 | 2018-02-27 | Mylan Laboratories Limited | Process for the preparation of empagliflozin |
| WO2016169534A1 (en) * | 2015-04-24 | 2016-10-27 | Zentiva, K. S. | Solid forms of amorphous empagliflozin |
| CN106317035A (zh) * | 2015-06-23 | 2017-01-11 | 中美华世通生物医药科技（武汉）有限公司 | 恩格列净单晶及其制备方法和用途 |
| US10428053B2 (en) | 2015-09-15 | 2019-10-01 | Laurus Labs Limited | Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof |
| US10738038B2 (en) | 2015-09-15 | 2020-08-11 | Laurus Labs Limited | Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof |
| US10836753B2 (en) | 2015-09-15 | 2020-11-17 | Laurus Labs Limited | Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof |
| US11040961B2 (en) | 2015-09-15 | 2021-06-22 | Laurus Labs Limited | Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof |
| WO2017203457A1 (en) * | 2016-05-26 | 2017-11-30 | Dr. Reddy's Laboratories Limited | Solid state forms of empagliflozin |
| WO2021123165A1 (en) | 2019-12-19 | 2021-06-24 | Krka, D.D., Novo Mesto | Dosage form comprising amorphous solid solution of empagliflozin with polymer |